# Eli Lilly and Company (LLY) — Q1-2024 Earnings Results

**Report date:** 2024-04-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q1-2024

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.58 | N/A | +1.94% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains cautiously optimistic about the company's future. They emphasized the potential of new products to drive revenue.

**Key quotes:**

> Management expressed confidence in the company's ongoing product pipeline.

> They highlighted the importance of upcoming drug launches for future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is currently not available, which may reflect investor caution amid the mixed information.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q1-2024_